Inovio Pharmaceuticals Inc (INO)

[Lakers_w]

CD8+ killer T cells also hunt and kill virus in infected cells, hence called cellular response. This makes 4800 highly potent.

4800 uses a team sport balanced strategy inducing both B humoral and T cell cellular responses in addition to nAb.

Imagining a single-dimensional defense that has a robust front-4 defensive line (NAb) but weak linebackers, cornerbacks, safety (CD4+ helper T cell), weak or non-existing defensive end rushing QB (CD8+ killer T cell).

That defense would be roasted by a good passing offense.

Another analogy to T cell long term memory aka durability, length of Immunity brought up by CEPI scientists is imagining the coach lost the playbook. He can’t send the play to the QB.

Or the players don’t remember well the plays practiced long before the game.

I’ve tried to dumb down as much as I can for layman’s.

JK can use the same analogy in Ino’s Analyst Day to educate analysts.

Investors can do the same to educate one another, shorts, or potential shorts.

Hope some of them understand American Football.

Analysts are so idiotic. JK needs to issue additional PR and holds Analyst day to educate them and clarify 4800 differentiating advantages. It’s reasonable if You fault JK for not doing just that.